Key regions: Australia, Europe, Canada, United States, Japan
The Wound Care market in BRICS countries is experiencing significant growth due to various factors such as increasing healthcare expenditure, rising aging population, and growing awareness about advanced wound care products.
Customer preferences: Customers in BRICS countries are increasingly opting for advanced wound care products and therapies. This is primarily driven by the rising prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, which require specialized treatment. Additionally, the increasing awareness about the benefits of advanced wound care products, such as faster healing and reduced risk of infection, is also influencing customer preferences.
Trends in the market: Brazil: The wound care market in Brazil is witnessing steady growth due to the rising prevalence of chronic wounds and an aging population. The demand for advanced wound care products, such as wound dressings and negative pressure wound therapy, is increasing as healthcare providers and patients seek more effective and efficient treatment options.Russia: In Russia, the wound care market is growing due to the increasing incidence of chronic wounds, especially among the elderly population. The demand for advanced wound care products, such as bioactive dressings and antimicrobial agents, is on the rise as healthcare providers focus on improving wound healing outcomes and reducing the risk of complications.India: The wound care market in India is expanding rapidly due to the growing healthcare infrastructure, increasing disposable income, and rising awareness about advanced wound care products. The demand for wound dressings, wound closure devices, and advanced wound care therapies is increasing as patients and healthcare providers seek better treatment options for chronic wounds.China: China's wound care market is experiencing significant growth due to the rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, and the increasing healthcare expenditure. The demand for advanced wound care products, such as wound dressings and wound care devices, is increasing as healthcare providers and patients seek innovative and effective treatment solutions.South Africa: In South Africa, the wound care market is growing due to the rising prevalence of chronic wounds, such as diabetic foot ulcers and venous leg ulcers, and the increasing adoption of advanced wound care products. The demand for wound dressings, wound care devices, and advanced wound care therapies is increasing as healthcare providers focus on improving patient outcomes and reducing healthcare costs.
Local special circumstances: Each BRICS country has its own unique set of circumstances that influence the wound care market. For example, Brazil has a large aging population, which contributes to the increasing demand for wound care products. In Russia, the prevalence of chronic wounds is high due to factors such as diabetes and cardiovascular diseases. India has a growing middle class with increasing disposable income, which drives the demand for advanced wound care products. China has a large population and a rapidly expanding healthcare sector, which creates opportunities for the wound care market. South Africa has a high burden of chronic wounds, especially among the diabetic population, which drives the demand for advanced wound care products.
Underlying macroeconomic factors: The growth of the wound care market in BRICS countries is also influenced by underlying macroeconomic factors. These include increasing healthcare expenditure, government initiatives to improve healthcare infrastructure, and the rising burden of chronic diseases. As BRICS countries continue to invest in their healthcare systems and focus on improving patient outcomes, the demand for advanced wound care products is expected to grow further. Additionally, the increasing prevalence of chronic wounds and the aging population in these countries will continue to drive the growth of the wound care market.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
